Adverse side effects associated with latanoprost.
OBJECTIVE
To report three different adverse reactions after initiating treatment with latanoprost.


METHODS
Serial clinical examinations of three patients were performed.


RESULTS
Adverse reactions such as ocular hypotony and choroidal effusions, recurrent cystoid macular edema, and facial rash were noted to occur within 1 to 4 weeks after starting topical latanoprost for the treatment of primary open-angle glaucoma.


CONCLUSIONS
Clinicians should be alerted to these possible complications of topical latanoprost therapy.
Rowe
J A
JA
Mayo Clinic, Rochester, MN 55905, USA.
Hattenhauer
M G
MG
Herman
D C
DC
D000368:Aged; D000369:Aged, 80 and over; D015862:Choroid Diseases / Q000139:chemically induced*; D005076:Exanthema / Q000139:chemically induced*; D005260:Female; D005451:Fluorescein Angiography; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure; D000077338:Latanoprost; D008269:Macular Edema / Q000139:chemically induced*; D008297:Male; D015814:Ocular Hypotension / Q000139:chemically induced*; D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage / Q000009:adverse effects*; D012008:Recurrence
D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost